Skip to main content

Weather alert

Due to winter storm Fern, our Patient Service Centers in affected areas may be closed. We ask that patients please double check your appointment status to ensure your designated Patient Service Center is operational. For site-specific information, please use Find a location and enter your zip code.

Hide
Quest Diagnostics

Development and Validation of a Comprehensive Dilute and Shoot LCMS Method: Qualitative Confirmation of 113 Drugs in Urine

SOFT 2023

Society of Forensic toxicologists

Denver, CO, Oct 29-Nov 3, 2023

Poster  presentation: Development and Validation of a Comprehensive Dilute and Shoot LCMS Method: Qualitative Confirmation of 113 Drugs in Urine

Authors: Hunt TJ, Sill DJ, Smith, MP Bartock SH

Specialty: Prescription Drug Monitorig, Toxicology

Related content

Audio Podcast
Drug Testing for Stimulants
Audio Podcast
Dangerous Drug Combinations
Test FAQ
Drug Monitoring Antidepressants With Confirmation Urine and Serum
Test FAQ
Drug Monitoring, Assess Panel, Comprehensive, Qualitative, Urine
Test FAQ
Pain Management Antipsychotics With Confirmation Serum and Urine
Test FAQ
Novel Psychoactive Substances (NPS) Panel

Our company

Quest® is the brand name used for services offered by Quest Diagnostics Incorporated and its affiliated companies. Quest Diagnostics Incorporated and certain affiliates are CLIA-certified laboratories that provide HIPAA-covered services.  Other affiliates operated under the Quest® brand, such as Quest Consumer Inc., do not provide HIPAA-covered services. 

 

Quest®, Quest Diagnostics®, any associated logos, and all associated Quest Diagnostics registered or unregistered trademarks are the property of Quest Diagnostics. All third-party marks—® and ™—are the property of their respective owners. © 2026 Quest Diagnostics Incorporated. All rights reserved. Image content features models and is intended for illustrative purposes only.